Symbol
iBio, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$3.80
Current price of the stock
$369K
Trading volume of the stock
$34.7M
Market capitalization of the company
Nano Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
13.16%
Potential price appreciation based on analyst price targets
-6.67%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.09
Total debt to total equity ratio
1.76
Current ratio
100.00%
Gross profit margin
-2209.50%
Operating profit margin
-2209.50%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-2182.00%
Pretax profit margin
-2182.00%
Net profit margin
-31.41%
Measures profitability relative to shareholders' equity
-56.04%
ROE excluding intangible assets
-20.11%
Measures profitability relative to total assets
-30.02%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
15.38
Receivables turnover ratio
5.85
Average number of days it takes to collect receivables
2.13
Measures valuation relative to earnings
-
P/E based on future earnings estimates
92.54
Measures valuation relative to sales
2.51
Measures valuation relative to book value
-0.39
Measures valuation relative to operating cash flow
-0.39
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
